{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:36:25Z","timestamp":1789565785213,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajic.2024.06.017","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T16:35:21Z","timestamp":1719333321000},"page":"1351-1358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical impact of active screening cultures for carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-418X","authenticated-orcid":false,"given":"Ili","family":"Margalit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digbijay","family":"Kunwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Meroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scardellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Zamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Koutsolioutsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2024.06.017_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2024.06.017_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.017_bib3","unstructured":"Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva: World Health Organization; 2017. Accessed June 19, 2024. https:\/\/pubmed.ncbi.nlm.nih.gov\/29630191\/."},{"key":"10.1016\/j.ajic.2024.06.017_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2024.06.017_bib5","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.15585\/mmwr.mm6948e1","article-title":"Increase in hospital-acquired carbapenem-resistant Acinetobacter baumannii infection and colonization in an acute care hospital during a surge in COVID-19 admissions - New Jersey, February-July 2020","volume":"69","author":"Perez","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2024.06.017_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhin.2018.12.013","article-title":"Acinetobacter - the trojan horse of infection control?","volume":"102","author":"Teare","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2024.06.017_bib7","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001735","article-title":"Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019","volume":"25","author":"L\u00f6tsch","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ajic.2024.06.017_bib8","unstructured":"Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs). Centers for Disease Control and Prevention (CDC); 2022. Accessed June 19, 2024. www.cdc.gov\/healthcare-associated-infections\/media\/pdfs\/Health-Response-Contain-MDRO-H.pdf."},{"key":"10.1016\/j.ajic.2024.06.017_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhin.2010.04.027","article-title":"Adverse effects of isolation in hospitalised patients: a systematic review","volume":"76","author":"Abad","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ajic.2024.06.017_bib10","first-page":"1571","article-title":"Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial","volume":"310","author":"Harris","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2024.06.017_bib11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajic.2024.06.017_bib12","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed June 19, 2024. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.ajic.2024.06.017_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajic.2024.06.017_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12686","article-title":"Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department","volume":"19","author":"Geladari","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.017_bib15","first-page":"235","article-title":"Rate and risk factors for carbapenem resistant Acinetobacter baumannii clinical infections in colonized patients","volume":"24","author":"Wiener-Well","year":"2022","journal-title":"ISR Med Assoc J"},{"key":"10.1016\/j.ajic.2024.06.017_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ijantimicag.2018.04.008","article-title":"NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia","volume":"52","author":"Maamar","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2024.06.017_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13756-017-0296-7","article-title":"Endemic carbapenem-nonsusceptible Acinetobacter baumannii-calcoaceticus complex in intensive care units of the national referral hospital in Jakarta, Indonesia","volume":"7","author":"Saharman","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ajic.2024.06.017_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01631-17","article-title":"Risk factors and outcomes associated with multidrug-resistant Acinetobacter baumannii upon intensive care unit admission","volume":"62","author":"Blanco","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2024.06.017_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ajic.2017.01.016","article-title":"Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: can it predict and reduce subsequent infections and the use of colistin?","volume":"45","author":"An","year":"2017","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2024.06.017_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/lt.24389","article-title":"Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: impact on recipient outcomes","volume":"22","author":"Freire","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ajic.2024.06.017_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/cid\/ciu847","article-title":"Surveillance cultures growing carbapenem-resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study","volume":"60","author":"Latibeaudiere","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.06.017_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/antibiotics11070911","article-title":"The impact of antimicrobial stewardship and infection control interventions on Acinetobacter baumannii resistance rates in the ICU of a Tertiary Care Center in Lebanon","volume":"11","author":"Rizk","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2024.06.017_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1017\/ice.2020.197","article-title":"Detecting carbapenem-resistant Acinetobacter baumannii (CRAB) carriage: Which body site should be cultured?","volume":"41","author":"Nutman","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2024.06.017_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03146-23","article-title":"Active surveillance for carbapenem-resistant Acinetobacter baumannii (CRAB) carriage","volume":"11","author":"Nutman","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ajic.2024.06.017_bib25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ajic.2020.11.012","article-title":"Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah","volume":"49","author":"Smith","year":"2021","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2024.06.017_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13054-018-2247-y","article-title":"An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital","volume":"22","author":"Ben-Chetrit","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.ajic.2024.06.017_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13756-021-00990-z","article-title":"A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit","volume":"10","author":"Meschiari","year":"2021","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324005789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324005789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T22:55:29Z","timestamp":1731538529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655324005789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0196655324005789"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2024.06.017","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact of active screening cultures for carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2024.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}